1. Home
  2. BMRA vs ABVC Comparison

BMRA vs ABVC Comparison

Compare BMRA & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
    SELLHOLDBUYas of 2 days ago
  • ABVC
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • BMRA 1971
  • ABVC 2015
  • Country
  • BMRA United States
  • ABVC United States
  • Employees
  • BMRA N/A
  • ABVC N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ABVC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • ABVC Health Care
  • Exchange
  • BMRA Nasdaq
  • ABVC Nasdaq
  • Market Cap
  • BMRA 4.5M
  • ABVC 6.5M
  • IPO Year
  • BMRA N/A
  • ABVC N/A
  • Fundamental
  • Price
  • BMRA $0.28
  • ABVC $0.52
  • Analyst Decision
  • BMRA
  • ABVC
  • Analyst Count
  • BMRA 0
  • ABVC 0
  • Target Price
  • BMRA N/A
  • ABVC N/A
  • AVG Volume (30 Days)
  • BMRA 2.4M
  • ABVC 372.9K
  • Earning Date
  • BMRA 01-14-2025
  • ABVC 11-14-2024
  • Dividend Yield
  • BMRA N/A
  • ABVC N/A
  • EPS Growth
  • BMRA N/A
  • ABVC N/A
  • EPS
  • BMRA N/A
  • ABVC N/A
  • Revenue
  • BMRA $5,509,000.00
  • ABVC $509,788.00
  • Revenue This Year
  • BMRA N/A
  • ABVC N/A
  • Revenue Next Year
  • BMRA N/A
  • ABVC N/A
  • P/E Ratio
  • BMRA N/A
  • ABVC N/A
  • Revenue Growth
  • BMRA 1.74
  • ABVC N/A
  • 52 Week Low
  • BMRA $0.24
  • ABVC $0.41
  • 52 Week High
  • BMRA $1.35
  • ABVC $2.45
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 40.95
  • ABVC 49.62
  • Support Level
  • BMRA $0.27
  • ABVC $0.46
  • Resistance Level
  • BMRA $0.48
  • ABVC $0.54
  • Average True Range (ATR)
  • BMRA 0.03
  • ABVC 0.04
  • MACD
  • BMRA -0.01
  • ABVC 0.00
  • Stochastic Oscillator
  • BMRA 9.56
  • ABVC 80.65

Stock Price Comparison Chart: BMRA vs ABVC

BMRA
ABVC
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober05101520253035404550556065BMRA VS ABVC

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use